{
  "ticker": "BCYC",
  "company_name": "Bicycle Therapeutics plc",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04180371",
      "title": "Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer, Non-small Cell Lung Cancer, Head and Neck Cancer, Triple Negative Breast Cancer, Gastric/Upper Gastrointestinal Cancer",
      "start_date": "2019-11-07",
      "completion_date": "2027-07-31",
      "enrollment": 0,
      "sponsor": "BicycleTx Limited"
    },
    {
      "nct_id": "NCT04561362",
      "title": "Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms, Hormone Receptor Positive, HER2-negative Neoplasms, Hormone Receptor Positive, HER2-low Neoplasms, Breast Neoplasms, Non-Small-Cell Lung Neoplasms, Ovarian Neoplasm, Advanced Solid Tumor",
      "start_date": "2020-07-17",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "BicycleTx Limited"
    },
    {
      "nct_id": "NCT06840483",
      "title": "Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Breast Cancer",
      "start_date": "2025-03-03",
      "completion_date": "2028-12-30",
      "enrollment": 0,
      "sponsor": "BicycleTx Limited"
    },
    {
      "nct_id": "NCT06225596",
      "title": "Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)",
      "status": "RECRUITING",
      "phase": "PHASE2, PHASE3",
      "condition": "Metastatic Urothelial Cancer",
      "start_date": "2024-01-24",
      "completion_date": "2030-12",
      "enrollment": 0,
      "sponsor": "BicycleTx Limited"
    },
    {
      "nct_id": "NCT06933329",
      "title": "Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Non-Small Cell Lung Cancer",
      "start_date": "2025-07-18",
      "completion_date": "2029-02-28",
      "enrollment": 0,
      "sponsor": "BicycleTx Limited"
    },
    {
      "nct_id": "NCT05163041",
      "title": "Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Advanced Solid Tumor",
      "start_date": "2021-11-02",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "BicycleTx Limited"
    },
    {
      "nct_id": "NCT03486730",
      "title": "BT1718 in Patients with Advanced Solid Tumours.",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Advanced Solid Tumours, Non-Small Cell Lung Cancer, Non-Small Cell Lung Sarcoma, Oesophageal Cancer",
      "start_date": "2018-01-24",
      "completion_date": "2023-11-20",
      "enrollment": 0,
      "sponsor": "Cancer Research UK"
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "PHASE1, PHASE2": 4,
      "PHASE2": 2,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 3,
      "RECRUITING": 3,
      "COMPLETED": 1
    },
    "active_trials": 6,
    "completed_trials": 1,
    "conditions": [
      "Advanced Solid Tumor",
      "Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer, Non-small Cell Lung Cancer, Head and Neck Cancer, Triple Negative Breast Cancer, Gastric/Upper Gastrointestinal Cancer",
      "Advanced Solid Tumours, Non-Small Cell Lung Cancer, Non-Small Cell Lung Sarcoma, Oesophageal Cancer",
      "Breast Cancer",
      "Metastatic Urothelial Cancer",
      "Non-Small Cell Lung Cancer",
      "Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms, Hormone Receptor Positive, HER2-negative Neoplasms, Hormone Receptor Positive, HER2-low Neoplasms, Breast Neoplasms, Non-Small-Cell Lung Neoplasms, Ovarian Neoplasm, Advanced Solid Tumor"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:04.861725",
    "search_query": "Bicycle Therapeutics plc",
    "url": "https://clinicaltrials.gov/search?term=Bicycle+Therapeutics+plc"
  }
}